These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3412101

  • 21. Postnatal changes in blood spot 17-hydroxyprogesterone level in healthy preterm and full-term neonates.
    Sulyok E, Sólyom J, Füller M, Kerekes L.
    Acta Paediatr Hung; ; 29(3-4):239-43. PubMed ID: 3269260
    [Abstract] [Full Text] [Related]

  • 22. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J.
    Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
    [Abstract] [Full Text] [Related]

  • 23. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
    Guechot J, Fiet J, Gourmelen M, Pham-Huu-Trung MT, Raux-Eurin MC, Brerault JL, Gueux B, Villette JM.
    Ann Biol Clin (Paris); 1985 Aug; 43(4):333-7. PubMed ID: 4091295
    [Abstract] [Full Text] [Related]

  • 24. [Value of 17-hydroxyprogesterone determination in exploration of adrenal cortex enzyme deficiencies].
    Fiet J, Pham-Huu-Trung MT, Dreux C, Girard F.
    C R Seances Soc Biol Fil; 1979 Aug; 173(2):504-14. PubMed ID: 159770
    [Abstract] [Full Text] [Related]

  • 25. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 26. Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in premature infants--proposal for cut-off limits in screening for congenital adrenal hyperplasia.
    Ohkubo S, Shimozawa K, Matsumoto M, Kitagawa T.
    Acta Paediatr Jpn; 1992 Apr; 34(2):126-33. PubMed ID: 1621517
    [Abstract] [Full Text] [Related]

  • 27. [Fluorescent enzyme immunoassay for 17 alpha-hydroxyprogesterone].
    Ikegami T, Maeda M, Tsuji A, Hosoda H, Nambara T.
    Yakugaku Zasshi; 1987 Feb; 107(2):150-6. PubMed ID: 3298613
    [No Abstract] [Full Text] [Related]

  • 28. [Plasma 17-alpha-hydroxyprogesterone concentration for the diagnosis of congenital adrenal hyperplasia (author's transl)].
    Dumić M, Kalafatić Z, Tajić M, Gjurić G, Mardesić D.
    Lijec Vjesn; 1980 Feb; 102(7-8):400-3. PubMed ID: 7289713
    [No Abstract] [Full Text] [Related]

  • 29. Usefulness and limitations of an in-house direct radioimmunoassay for 17-hydroxyprogesterone in serum.
    Lo MS, Ng ML, Wu LL, Azmy BS, Khalid BA.
    Malays J Pathol; 1996 Jun; 18(1):43-52. PubMed ID: 10879224
    [Abstract] [Full Text] [Related]

  • 30. [17-Hydroxyprogesterone].
    Watanabe F.
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():471-3. PubMed ID: 8753283
    [No Abstract] [Full Text] [Related]

  • 31. Thrombocytosis in congenital adrenal hyperplasia at diagnosis.
    Gasparini N, Franzese A, Argenziano A, Di Maio S, Tenore A.
    Clin Pediatr (Phila); 1996 May; 35(5):267-9. PubMed ID: 8804546
    [No Abstract] [Full Text] [Related]

  • 32. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
    Sólyom J, Hosszu E, Gács G.
    Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
    [Abstract] [Full Text] [Related]

  • 33. Value of selective screening for congenital adrenal hyperplasia in Hungary.
    Sólyom J, Hughes IA.
    Arch Dis Child; 1989 Mar; 64(3):338-42. PubMed ID: 2705794
    [Abstract] [Full Text] [Related]

  • 34. [Prenatal diagnosis and treatment of congenital adrenal gland hyperplasia].
    Igea García JM, Martul Tobio P, Loridan Stienlet L, Pineda Algorta J.
    An Esp Pediatr; 1992 Jun; 36 Suppl 49():138-40. PubMed ID: 1416452
    [No Abstract] [Full Text] [Related]

  • 35. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 36. [Enzyme immunoassay for 17-hydroxyprogesterone in serum and saliva and from blood microfilter paper and microtitration plates].
    Füssel M, Hubl W, Weber S, Ilchmann D, Neef B, Hoepffner W.
    Z Med Lab Diagn; 1988 Jan; 29(3):152-8. PubMed ID: 3043958
    [No Abstract] [Full Text] [Related]

  • 37. [Therapeutic monitoring in congenital adrenal hyperplasia using C.I.S. 17-alpha-hydroxyprogesterone radioimmunoassay kit (author's transl)].
    Nakajima F, Machida Y, Amano T, Oya N, Sawada J.
    Horumon To Rinsho; 1980 Jan; 28(5):601-5. PubMed ID: 7389169
    [No Abstract] [Full Text] [Related]

  • 38. Measurement of androstenedione levels by an in-house radioimmunoassay.
    Lo MS, Ng ML, Wu LL, Khalid BA.
    Malays J Pathol; 1996 Jun; 18(1):53-8. PubMed ID: 10879225
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of adrenal 21-hydroxylase deficiency in neonates born in the West Midlands: a retrospective study.
    Rudd BT.
    J Inherit Metab Dis; 1986 Jun; 9 Suppl 1():155-6. PubMed ID: 3097416
    [No Abstract] [Full Text] [Related]

  • 40. Neonatal screening for congenital adrenal hyperplasia using a microfilter paper method for 17-alpha-hydroxyprogesterone radioimmunoassay. Experience gained from the study of 22,233 cases.
    Cacciari E, Balsamo A, Cassio A, Piazzi S, Bernardi F, Salardi S, Cicognani A, Pirazzoli P, Zappulla F, Capelli M, Paolini M.
    Horm Res; 1982 Jun; 16(1):4-9. PubMed ID: 7068111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.